1
|
Dormán G, Szalai Z, Keglevich G. Cytotoxic Activity of Distinct Families of Phosphonic Acid Derivatives - A Chemocentric Approach to Assess Their Molecular Action. ChemMedChem 2024:e202400370. [PMID: 38965788 DOI: 10.1002/cmdc.202400370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Revised: 07/04/2024] [Accepted: 07/04/2024] [Indexed: 07/06/2024]
Abstract
Phosphorus containing small molecules (particularly α-aminophosphonates, α-hydroxyphosphonates and bisphosphonates) represent a unique chemical space among the biologically active compounds. We selected 35 diverse compounds that showed remarkable cytotoxicity effects on various cancer cell lines. However, the exact mechanism of action often requires further investigations, in vitro or in silico target identification even though many target-based activity data were gathered for the above cluster of compounds. In our conceptual account, we offer a systematic in silico analysis between the cytotoxicity, cell lines, their (over)expressed protein targets associated with malignant diseases, and the activity data on protein targets already reported for those compounds in the hope that we gain better understanding and explanation, what is behind their cytotoxic behavior.
Collapse
Affiliation(s)
- György Dormán
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1111, Budapest, Műegyetem rkp. 3., Hungary
- TargetEx llc., 2120, Dunakeszi, Madách Imre Street 31/2., Hungary
| | - Zsuzsanna Szalai
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1111, Budapest, Műegyetem rkp. 3., Hungary
| | - György Keglevich
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1111, Budapest, Műegyetem rkp. 3., Hungary
| |
Collapse
|
2
|
Tsacheva I, Todorova Z, Momekova D, Momekov G, Koseva N. Pharmacological Activities of Schiff Bases and Their Derivatives with Low and High Molecular Phosphonates. Pharmaceuticals (Basel) 2023; 16:938. [PMID: 37513849 PMCID: PMC10386503 DOI: 10.3390/ph16070938] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 06/21/2023] [Accepted: 06/22/2023] [Indexed: 07/30/2023] Open
Abstract
This review paper is focused on the design of anthracene and furan-containing Schiff bases and their advanced properties as ligands in complex transition metal ions The paper also provides a brief overview on a variety of biological applications, namely, potent candidates with antibacterial and antifungal activity, antioxidant and chemosensing properties. These advantageous properties are enhanced upon metal complexing. The subject of the review has been extended with a brief discussion on reactivity of Schiff bases with hydrogen phosphonates and the preparation of low and high molecular phosphonates, as well as their application as pharmacological agents. This work will be of interest for scientists seeking new challenges in discovering advanced pharmacological active molecules gaining inspiration from the versatile families of imines and aminophosphonates.
Collapse
Affiliation(s)
- Ivelina Tsacheva
- Institute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, 1113 Sofia, Bulgaria
| | - Zornica Todorova
- Institute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, 1113 Sofia, Bulgaria
| | - Denitsa Momekova
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
| | - Georgi Momekov
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
| | - Neli Koseva
- Bulgarian Academy of Sciences, 1 "15 Noemvri" Str., 1040 Sofia, Bulgaria
| |
Collapse
|
3
|
Cheng L, Wang Y, Wang J, Qin H, Zhu G, Tao L. Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines. JOURNAL OF HEALTHCARE ENGINEERING 2022; 2022:4993405. [PMID: 35345664 PMCID: PMC8957437 DOI: 10.1155/2022/4993405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 01/07/2022] [Accepted: 01/20/2022] [Indexed: 11/30/2022]
Abstract
Objective Prostate cancer is one of the most common types of cancer found to occur in males and is ranked as the second-highest cause of cancer-associated deaths among male patients. In this study, we have shown the influence of a new palladium-based anticancer agent in contrast to the six distinct prostate cancer lines and the primary cultures. Methods In this study, we have used six distinct prostate cell lines, that is, PNT2-C2, LNCaP, BPH-1, PC-3, PNT1A, and P4E6. The MTP and ATP assay were performed to evaluate the growth of the cell and the flow cytometry to investigate the status of the cell cycle. The antigrowth effect of the palladium complex was evaluated against different cell lines at three time zones 24 h, 48 h, and 72 h. [PdCl(terpy)] (capsule)-2H2O is synthesized by direct encapsulation of equimolar amounts of capsule ions into [Pd (terpy) Cl] Cl-2H2O. Results A comparative analysis was done on 25 mM etoposide and 12 mM cisplatin, cytotoxic agents. The lowest IC50 value at 72 hours was 0.128 mM for BPH-1 cell lines with 0.139 mM, whereas PNT2-C2 cells were found to be most resistant with IC50 values of 0.829 mM. The antigrowth effect of palladium complex on cell lines was measured using the MTS assay at 24, 48, and 72 hours. BPH-1, PNT2-C2, and PNT1A either possess normal tissues or have benign prostatic hyperplasia tissues whereas P4E6, PC-3, and LNCaP cell lines possess malignant origin. The Pd complex exhibited significant cytotoxic action in stem cells when compared against etoposide. An antigrowth effect was reported for Pd complex at lower concentration, but it was more cytotoxic than etoposide with significant cytotoxicity (P=0.001). Conclusion The palladium complex experienced a substantial antigrowth influence over most of the prostate tumor cell lines and the primary cultures, eventually, leading to the implementation of this Pd complex in the treating procedure of metastatic prostate cancer, which is tremendously resistant to the traditional treatment.
Collapse
Affiliation(s)
- Long Cheng
- Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| | - Yan Wang
- Department of Pathology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| | - Jiawei Wang
- Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| | - Haibo Qin
- Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| | - Guangbiao Zhu
- Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| | - Lingsong Tao
- Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui Province, China
| |
Collapse
|
4
|
Lei G, Liu S, Yang X, He C. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Can J Gastroenterol Hepatol 2021; 2021:8870907. [PMID: 33824865 PMCID: PMC8007381 DOI: 10.1155/2021/8870907] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Revised: 02/25/2021] [Accepted: 03/09/2021] [Indexed: 02/08/2023] Open
Abstract
Background Oxaliplatin is the first-choice chemotherapy method for patients with advanced colon cancer. However, its resistance leads to treatment failure for many patients. In our experiments, we aim to elucidate the associations among TRIM29 protein, mutant P53, and the resistance of colon cancer cells to oxaliplatin. Methods HCT116 and HT-29 cells were cultured and transfected with plasmids pIRES2-ZsGreen1-TRIM29-flag. Western blot and real-time qRT-PCR were utilized to examine the protein and mRNA expressions of TRIM29 and other related markers, respectively. MTT assay was utilized to determine the cell growth rate and generate the inhibition curve. Continuous culture in low-concentration oxaliplatin was conducted to construct oxaliplatin-resistant cell lines. The coimmunoprecipitation method and immunofluorescence detection were used to examine the interaction between TRIM29 and mutant P53 protein in HT29 cells. Results We successfully transfected pIRES2-ZsGreen1-TRIM29-flag into HCT116 and HT29 cells, which were utilized in the whole experiments. TRIM29 significantly increased the sensitivity of P53 mutant colon cancer cell HT29 to oxaliplatin. The oxaliplatin-resistant model of P53 mutant colon cancer cell HT29 was successfully constructed. TRIM29 physically bound with mutant P53 and retained it in the cytoplasm from the nucleus, which inhibited its transcription function of downstream genes such as MDR1. In addition, TRIM29 successfully reversed the resistance of HT29-OX resistant cell model to oxaliplatin. Conclusion In mutant P53 colon cancer cell HT29, TRIM29 greatly increased the sensitivity of HT29 to oxaliplatin and reverse oxaliplatin resistance. The underlying mechanism is TRIM29 may increase the sensitivity of HT29 to oxaliplatin by blocking the transcriptional function of mutant P53, which inhibits the transcription function of its downstream gene such as MDR1.
Collapse
Affiliation(s)
- Guoqiong Lei
- Department of Neurosurgery, The Second People's Hospital of Hunan Province, Changsha, Hunan 410007, China
| | - Sushun Liu
- Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
| | - Xin Yang
- Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
| | - Chao He
- Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
| |
Collapse
|
5
|
Lu D, Zhou Y, Li Q, Luo J, Jiang Q, He B, Tang Q. Synthesis, In Vitro Antitumor Activity and Molecular Mechanism of Novel Furan Derivatives and their Precursors. Anticancer Agents Med Chem 2020; 20:1475-1486. [PMID: 32329695 DOI: 10.2174/1871520620666200424130204] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Revised: 03/05/2020] [Accepted: 03/27/2020] [Indexed: 12/27/2022]
Abstract
BACKGROUND Compounds featuring furan nucleus exhibit diverse biological properties. Lots of furan derivatives have been explored as pharmaceutical compounds. Hence it is of great interest to explore furan derivatives and their precursors as antitumor agents. OBJECTIVE A series of novel furan derivatives and their precursors (1-36) were synthesized from α-haloketones and β-dicarbonyl compounds. METHODS The reactions between β-dicarbonyl compounds and α-haloketones under basic conditions produced tricarbonyls or dihydrofurans, which were then condensed into their corresponding furan products. Their potential antiproliferative activity in vitro against two human tumor cell lines-cervical (HeLa) and colorectal (SW620) was evaluated using CCK-8 assay. Compounds 1 and 24 were selected for Western blot analysis. RESULTS Pronounced anti-proliferative effect in the micromolar level was observed for compounds (1, 4, 17, 20, 21, 24, 27, 31 and 32) in HeLa cells, with their IC50 values ranging from 0.08 to 8.79μM. Additionally, furan compounds (24, 26, 32 and 35) had moderate to potent anti-proliferative activity against the SW620 cell line. Furthermore, the possible targets of these compounds were explored by Western blot analysis. The results indicated that the candidates (compounds 1 and 24) exhibited excellent antiproliferative activity, which may be mediated by promoting the activity of PTEN to suppress PI3K/Akt and Wnt/β-catenin signaling. CONCLUSION Most of the furan derivatives and their precursors reported herein exhibited moderate to excellent anti-proliferative activity against HeLa cell line and/or SW620 cell line. Compounds 1 and 24, as well as their analogues may be developed as promising anti-cancer agents.
Collapse
Affiliation(s)
- Dan Lu
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Ya Zhou
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Qin Li
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Juan Luo
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Qihua Jiang
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Baicheng He
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| | - Qiang Tang
- College of Pharmacy, Center for Lab Teaching and Management, Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, No.1 Yixueyuan Road, Chongqing 400016, China
| |
Collapse
|